Followers | 125 |
Posts | 5428 |
Boards Moderated | 0 |
Alias Born | 06/09/2020 |
![](https://investorshub.advfn.com/uicon/747853.png?cb=1644300972)
Saturday, November 11, 2023 11:46:19 AM
You’ve seen them try to discredit every doctor who has anything bad to say about the crappy trial design and data
Lets look at conflict of interests.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171646559
They claim it’s that they are all paid by NVCR until I pointed to the 4 “authors” of the JAMA trial that were also involved in the Optune trial. And Musella would choose Optune if he was diagnosed with GBM.
Oh you like Al Musella?
Great lets see how he debunked the Novocure affiliated fanboy Matt Williams
![](http://i.postimg.cc/3JJwVwsk/12.jpg)
And how Al Musella debunked yet another BS article about the DCVax-L trial
![](http://i.postimg.cc/02HQ7sbh/10.jpg)
You have bullshitted about what Al Musella said about Optune countless times. You always end up ending his words abrubtly and leaving out what he ACTUALLY ALSO HAS said, especially after the results from immunotherapy trials cane out. Because you're paid to, we know.
This was your selective "excerpt"
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172442573
This is the whole article, with updates to his original words ... FROM 2017
https://virtualtrials.org/newsarticle.cfm?item=6333
2. A few immunotherapy trials have each shown about a tail of about 20% long term survivors, most in excellent condition. I would try to get one. Nobody knows which is best yet so get the one you can get fastest.
Nice bullshitted ... again
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM